These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32752128)

  • 1. CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC.
    Paulsen FO; Idel C; Ribbat-Idel J; Kuppler P; Klapper L; Rades D; Bruchhage KL; Wollenberg B; Brägelmann J; Perner S; Offermann A
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased mediator complex subunit CDK19 expression associates with aggressive prostate cancer.
    Becker F; Joerg V; Hupe MC; Roth D; Krupar R; Lubczyk V; Kuefer R; Sailer V; Duensing S; Kirfel J; Merseburger AS; Brägelmann J; Perner S; Offermann A
    Int J Cancer; 2020 Jan; 146(2):577-588. PubMed ID: 31271443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer.
    Brägelmann J; Klümper N; Offermann A; von Mässenhausen A; Böhm D; Deng M; Queisser A; Sanders C; Syring I; Merseburger AS; Vogel W; Sievers E; Vlasic I; Carlsson J; Andrén O; Brossart P; Duensing S; Svensson MA; Adler D; Kirfel J; Perner S
    Clin Cancer Res; 2017 Apr; 23(7):1829-1840. PubMed ID: 27678455
    [No Abstract]   [Full Text] [Related]  

  • 4. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
    Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
    Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
    Huang L; David O; Cabay RJ; Valyi-Nagy K; Macias V; Zhong R; Wenig B; Feldman L; Weichselbaum R; Spiotto MT
    Clin Cancer Res; 2019 Mar; 25(6):1795-1808. PubMed ID: 30573692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular characteristics of recurrent/metastatic HPV-positive head and neck squamous cell carcinoma: A systematic review of the literature.
    Flach S; Maniam P; Hey SY; Manickavasagam J
    Clin Otolaryngol; 2024 Jul; 49(4):384-403. PubMed ID: 38658385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse model of postsurgical primary tumor recurrence and regional lymph node metastasis progression in HPV-related head and neck cancer.
    Mermod M; Hiou-Feige A; Bovay E; Roh V; Sponarova J; Bongiovanni M; Vermeer DW; Lee JH; Petrova TV; Rivals JP; Monnier Y; Tolstonog GV; Simon C
    Int J Cancer; 2018 Jun; 142(12):2518-2528. PubMed ID: 29313973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD-1 and PD-L1 expression in HNSCC primary cancer and related lymph node metastasis - impact on clinical outcome.
    Schneider S; Kadletz L; Wiebringhaus R; Kenner L; Selzer E; Füreder T; Rajky O; Berghoff AS; Preusser M; Heiduschka G
    Histopathology; 2018 Oct; 73(4):573-584. PubMed ID: 29742291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the cancer stem cell marker DCLK1 in patients with lymph node metastases of head and neck cancer.
    Kadletz L; Kenner L; Wiebringhaus R; Jank B; Mayer C; Gurnhofer E; Konrad S; Heiduschka G
    Pathol Res Pract; 2019 Dec; 215(12):152698. PubMed ID: 31706685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV infection in oropharyngeal squamous cell carcinomas: correlation with tumor size.
    Gletsou E; Papadas TA; Baliou E; Tsiambas E; Ragos V; Armata IE; Metaxas GE; Fotiades PP
    J BUON; 2018; 23(2):433-438. PubMed ID: 29745089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19.
    Park MJ; Shen H; Spaeth JM; Tolvanen JH; Failor C; Knudtson JF; McLaughlin J; Halder SK; Yang Q; Bulun SE; Al-Hendy A; Schenken RS; Aaltonen LA; Boyer TG
    J Biol Chem; 2018 Mar; 293(13):4870-4882. PubMed ID: 29440396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC.
    Coppock JD; Vermeer PD; Vermeer DW; Lee KM; Miskimins WK; Spanos WC; Lee JH
    Oncotarget; 2016 Apr; 7(17):24228-41. PubMed ID: 27015118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC.
    von Bernuth A; Ribbat-Idel J; Klapper L; Jagomast T; Rades D; Leichtle A; Pries R; Bruchhage KL; Perner S; Offermann A; Sailer V; Idel C
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC.
    Rieke DT; Keilholz U
    Recent Results Cancer Res; 2017; 206():149-160. PubMed ID: 27699536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lnc-IL17RA-11 with increased radiation sensitivity and improved prognosis of HPV-positive HNSCC.
    Song L; Xie H; Tong F; Yan B; Zhang S; Fu E; Jing Q; Wei L
    J Cell Biochem; 2019 Oct; 120(10):17438-17448. PubMed ID: 31119798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate tumor overexpressed-1, in conjunction with human papillomavirus status, predicts outcome in early-stage human laryngeal squamous cell carcinoma.
    Yang L; Wang H; Wang Y; He Z; Chen H; Liang S; He S; Wu S; Song L; Chen Y
    Oncotarget; 2016 May; 7(22):31878-91. PubMed ID: 26992242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated nomogram combining lncRNAs classifier and clinicopathologic factors to predict the recurrence of head and neck squamous cell carcinoma.
    Cui J; Wen Q; Tan X; Piao J; Zhang Q; Wang Q; He L; Wang Y; Chen Z; Liu G
    Sci Rep; 2019 Nov; 9(1):17460. PubMed ID: 31767907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial.
    Adkins D; Ley J; Neupane P; Worden F; Sacco AG; Palka K; Grilley-Olson JE; Maggiore R; Salama NN; Trinkaus K; Van Tine BA; Steuer CE; Saba NF; Oppelt P
    Lancet Oncol; 2019 Sep; 20(9):1295-1305. PubMed ID: 31351869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteins.
    Chen M; Li J; Zhang L; Wang L; Cheng C; Ji H; Altilia S; Ding X; Cai G; Altomare D; Shtutman M; Byrum SD; Mackintosh SG; Feoktistov A; Soshnikova N; Mogila VA; Tatarskiy V; Erokhin M; Chetverina D; Prawira A; Ni Y; Urban S; McInnes C; Broude EV; Roninson IB
    Nucleic Acids Res; 2023 Aug; 51(14):7288-7313. PubMed ID: 37378433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.